What’s Next? Eli Lilly’s Lartruvo Flunks Sarcoma Trial
The 20 Hottest Pipeline Drugs to Watch in 2019
German Merck boosts autoimmune BTK inhibitor chase
7 drugmakers to watch on Q3 earnings
By many standards, and certainly by the way the media covers it and industry promotes it, immuno-oncology therapies using CAR-T are revolutionizing cancer treatments. But what if, as the saying … Continue Reading Does CAR-T Therapy Have a Payment Problem?
For years, the foundations of cancer treatment were surgery, chemotherapy, and radiation therapy. Over the last two decades, targeted therapies like imatinib (Gleevec®)and trastuzumab (Herceptin®)—drugs that target cancer cells by homing in on specific molecular … Continue Reading CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers
Researchers have designed nanoparticles that can be attached to T-cells and release T-cell-stimulating molecules called cytokines, that activate T-cells to attack nearby tumour cells. Programming the body’s immune system … Continue Reading Drugs Carried in Cellular ‘Backpacks’ Help T-Cells to Destroy Tumours
All you need to know about the rapidly evolving cancer treatment landscape and its economic impact. All the recent launches, highly anticipated new immuno-therapies and future trends. A … Continue Reading Global Trends in Oncology – 2018